medigraphic.com
ISSN 1527-3172 (Digital)

2022, Número 3-4

<< Anterior Siguiente >>

MEDICC Review 2022; 24 (3-4)


High Levels of Serum Bile Acids in COVID-19 Patients on Hospital Admission

Piñol-Jiménez FN, Capó-de Paz V, Ruiz-Torres JF, Montero-González T, Urgellés-Carreras SA, Breto-García A, Amador-Armenteros A, Llerena-Mesa MM, Galarraga-Lazcano AG

Idioma: Ingles.
Referencias bibliográficas: 19
Paginas: 53-56
Archivo PDF: 147.36 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Wieland H, Dane E. The constitution of the bileacids. II. The place of attachment of the sidechain. Z Physiol Chem. 1933;219:240‒44.

  2. Fiorucci S, Distrutti E, Carino A, ZampellaA, Biagioli M. Bile acids and their receptorsin metabolic disorders. Prog Lipid Res. 2021Apr;82:101094. https://doi.org/10.1016/j.plipres.2021.101094

  3. Wang Y, Yutuc E, Griffi ths WJ. Cholesterolmetabolism pathways - are the intermediatesmore important than the products? FEBS J. 2021Jun;288(12):3727‒45. https://doi.org/10.1111/febs.15727

  4. Yang J, Palmiotti A, Kuipers F. Emerging roles ofbile acids in control of intestinal functions. Curr OpinClin Nutr Metab Care. 2021 Mar 1;24(2):127‒33.https://doi.org/10.1097/MCO.0000000000000709

  5. Perino A, Demagny H, Velázquez-Villegas L,Schoonjans K. Molecular physiology of bile acidsignaling in health, disease, and aging. PhysiolRev. 2021 Apr 1;101(2):683‒731. https://dx.doi.org/10.1152/physrev

  6. Fiorucci S, Carino A, Baldoni M, Santucci L,Costanzi E, Graziosi L, et al. Bile acid signalingin infl ammatory bowel diseases. Dig Dis Sci.2021 Mar;66(3):674‒93. https://doi.org/10.1007/s10620-020-06715-3

  7. Manzotti C, Casazza G, Stimac T, Nikolova D,Gluud C. Total serum bile acids or serum bile acidprofi le, or both, for the diagnosis of intrahepaticcholestasis of pregnancy. Cochrane DatabaseSyst Rev. 2019 Jul;7(7):CD012546. https://doi.org/10.1002/14651858

  8. Wang H, Yan D, Li Y, Gong Y, Mai Y, Li B, et al. Clinicaland antibody characteristics reveal diverse signaturesof severe and non-severe SARS-CoV-2patients. Infect Dis Poverty. 2022 Feb 2;11(1):15.https://doi.org/10.186/s40249 - 0 2 2 - 0 0 940-w

  9. Ácidos biliares. Para la determinación in vitro deácidos biliares en suero o plasma EDTA frescoen sistema fotométricos [Internet]. Holzheim(DE): DiaSys Diagnostic Systems GmbH; 2007Jan [cited 2021 Sep 21]. 2 p. Available at: https://www.red-gdl.com/wp-content/uploads/2014/06/Acidos-biliares.pdf. Spanish.

  10. Roy A, Premkumar M, Mishra S, Mehtani R,Suri V, Aggarwal N, et al. Role of ursodeoxycholicacid on maternal serum bile acids andperinatal outcomes in intrahepatic cholestasisof pregnancy. Eur J Gastroenterol Hepatol.2021 Apr 1;33(4):571‒6. https://doi.org/10.1097/MEG.0000000000001954

  11. Mejías Sánchez Y, Morales Suárez I, ArteagaGarcía A, Alfonso Sánchez I. Estructuración delprotocolo cubano de actuación para la atenciónde casos COVID-19. Rev Cubana Salud Pública[Internet]. 2021 [cited 2021 Sep 21];47(3):e2922.Available at: http://www.revsaludpublica.sld.cu/index.php/spu/article/download/2922/1728.Spanish.

  12. Suardíaz Parera JH, Cruz Rodríguez CL, ColinaRodríguez AJ y colaboradores. LaboratorioClínico [Internet]. Havana: ECIMED; 2013 [cited2021 Sep 21]. XIV. 662 p. ISBN: 959-212-120-6. Available at: http://www.bvscuba.sld.cu/libro/laboratorio-clinico/. Spanish.

  13. World Medical Association (WMA). WMA Declarationof Helsinki - Ethical principles for medicalresearch involving human beings [Internet].Ferney-Voltaire (FR): World Medical Association(WMA); 2013 Oct [cited 2021 Sep 21]. Availableat: https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/#:~:text=Medical%20research%20involving%20human%20subjects%20must%20be%20conducted%20only%20by,or%20other%20health%20care%20professional

  14. Sharma A, Ahmad Farouk I, Kumar Lal S.COVID-19: a review on the novel Coronavirusdisease evolution, transmission, detection,control and prevention. Viruses. 2021 Jan29;13(2):202. https://doi.org/10.3390/v13020202

  15. Kočar E, Režen T, Rozman D. Cholesterol,lipoproteins, and COVID-19: basic conceptsand clinical applications. Biochim Biophys ActaMol Cell Biol Lipids. 2021 Feb;1866(2):158849.https://doi.org/10.1016/j.bbalip.2020.158849

  16. Rojas M, Rodríguez Y, Zapata E, Hernández JC,Anaya JM. Cholangiopathy as part of post-COVIDsyndrome. J Transl Autoimmun. 2021;4:100116.https://doi.org/10.1016/j.jtauto.2021.100116

  17. Sajdel-Sulkowska EM. A dual-route perspectiveof SARS-CoV-2 infection: lung- vs. gut-specifi ceff ects of ACE-2 defi ciency. Front Pharmacol.2021 Jun 11;12:684610. https://doi.org/10.3389/fphar.2021.684610

  18. Ballanamada Appaiah NN, Boyle K, Rogers D,Stewart J, Baker M. Intestinal failure: epidemiology,catheter-related sepsis and challenges.Cureus. 2021 Jul 1;13(7):e16093. https://doi.org/10.7759/cureus.16093

  19. World Health Organization [Internet]. Geneva:World Health Organization; c2022. Publications.Overview. Living guidance for clinical managementof COVID-19; 2021 Nov 23 [cited 2022Jul 10]; [2.4 MB]. Available at: https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-2




2020     |     www.medigraphic.com